abstract |
The present invention relates to thymosin β4 (Tβ4) derivatives, Gly-Tβ4 and Ala-Tβ4. The present invention further relates to a pharmaceutical composition comprising the Tβ4 derivative. The invention also relates to a method of using said Tβ4 derivative in the manufacture of a medicament for the treatment of skin damage, heart damage, corneal damage and / or coronary heart disease. The present invention further relates to a method for treating skin injury, heart injury, corneal injury and / or coronary heart disease by using said Tβ4 derivative. |